EHAB vs. AVAH, AHCO, ADUS, PEPG, ZIMV, TBPH, FULC, LXEO, CRBP, and BMEA
Should you be buying Enhabit stock or one of its competitors? The main competitors of Enhabit include Aveanna Healthcare (AVAH), AdaptHealth (AHCO), Addus HomeCare (ADUS), PepGen (PEPG), ZimVie (ZIMV), Theravance Biopharma (TBPH), Fulcrum Therapeutics (FULC), Lexeo Therapeutics (LXEO), Corbus Pharmaceuticals (CRBP), and Biomea Fusion (BMEA). These companies are all part of the "medical" sector.
Aveanna Healthcare (NASDAQ:AVAH) and Enhabit (NYSE:EHAB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.
Aveanna Healthcare has a net margin of -5.92% compared to Aveanna Healthcare's net margin of -7.95%. Aveanna Healthcare's return on equity of 1.43% beat Enhabit's return on equity.
Aveanna Healthcare has a beta of 2.02, indicating that its share price is 102% more volatile than the S&P 500. Comparatively, Enhabit has a beta of 1.98, indicating that its share price is 98% more volatile than the S&P 500.
Enhabit has lower revenue, but higher earnings than Aveanna Healthcare. Enhabit is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
Aveanna Healthcare received 21 more outperform votes than Enhabit when rated by MarketBeat users. Likewise, 38.71% of users gave Aveanna Healthcare an outperform vote while only 12.00% of users gave Enhabit an outperform vote.
Aveanna Healthcare presently has a consensus price target of $1.80, indicating a potential downside of 37.06%. Enhabit has a consensus price target of $10.13, indicating a potential upside of 17.73%. Given Aveanna Healthcare's stronger consensus rating and higher probable upside, analysts plainly believe Enhabit is more favorable than Aveanna Healthcare.
In the previous week, Enhabit had 23 more articles in the media than Aveanna Healthcare. MarketBeat recorded 25 mentions for Enhabit and 2 mentions for Aveanna Healthcare. Enhabit's average media sentiment score of 1.23 beat Aveanna Healthcare's score of 0.71 indicating that Aveanna Healthcare is being referred to more favorably in the media.
88.0% of Aveanna Healthcare shares are held by institutional investors. 7.8% of Aveanna Healthcare shares are held by insiders. Comparatively, 1.9% of Enhabit shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Aveanna Healthcare beats Enhabit on 11 of the 18 factors compared between the two stocks.
Get Enhabit News Delivered to You Automatically
Sign up to receive the latest news and ratings for EHAB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EHAB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
